SOD1 and early-onset autosomal dominant Alzheimer disease: Using the TgCRND8 Alzheimer’s disease model, which is a transgenic mouse model that presents an aberrant cleavage of the amyloid β precursor, it has been demonstrated that oral SOD supplementation reduces thiol levels in plasma [181].